Mice with human brain cells open a new path to studying brain disease

Overview

Updated 59 minutes ago

Stanford scientists created mice that grow lab-grown human neurons where their own brain cells were — the deepest integration yet of human tissue into an animal brain. The team depleted roughly 14 million native mouse cortical neurons and gave 4 million human ones room to expand.

The animals let researchers study disorders that only strike humans — autism, schizophrenia, epilepsy, cerebral palsy — and test drugs against living human tissue. But Duke Law professor Nita Farahany, who served on the study's ethics board, says the work enters "new gray areas for which there are not clear ethical guidelines or norms."

Why it matters

Scientists can now watch human brain tissue develop and fail inside a living animal — and test drugs for disorders that only strike humans.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

4 million

Human neurons transplanted per mouse

Lab-grown human cortical neurons added to each mouse brain after native neurons were depleted.

14 million

Native mouse neurons depleted

Mouse cortical neurons removed to make room for the human cells.

6 months

Human organoid growth before halt

Experiments stopped when human neurons reached roughly six months of development, before markers of consciousness.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

People Involved

Sergiu Pașca

Neuroscientist at Stanford University, study co-author

Leading the xenocortical mouse research program

Nita Farahany

Professor of law and philosophy, Duke Law School; ethics board member

Served unpaid on the external ethics board guiding the research

Madeline Lancaster

Developmental neurobiologist, University of Cambridge

Not involved in the study; commented on its implications

Hongkui Zeng

Executive vice president, Allen Institute for Brain Science

Commented publicly on the ethics of extending the work to larger animals

Jürgen Knoblich

Researcher, Institute of Molecular Biotechnology, Vienna

Pioneer in organoid research; commented on the study

Organizations Involved

Stanford University

Research university

Hosts the lab that led the study

Research university whose neuroscience lab led the xenocortical mouse study.

Nature

Scientific journal

Published the study and accompanying analysis

Peer-reviewed journal that published the xenocortical mouse study.

Allen Institute for Brain Science

Research institute

Leadership commented on the study's ethical implications

Brain research institute whose leadership cautioned that primate or pig experiments would raise larger ethical questions.

Timeline

January 2022 September 2026

4 events Latest: Today

Tap a bar to jump to that date

September 2026
Xenocortical mouse study published in Nature
Today Research

Mice grow human neurons after native cells depleted, enabling disease models.
Today
January 2025
Ethics panel convened
Ethics

Pașca convenes ethics experts to weigh neural organoid technology implications.
January 1st, 2025
January 2024
Organoid-bearing rats used for drug testing
Research

Same team tests antisense drugs for Timothy syndrome in organoid-bearing rats.
January 1st, 2024
January 2022
Human organoids transplanted into newborn rats
Research

Pașca's lab shows human organoids can mature and wire into newborn rat brains.
January 1st, 2022

Scenarios

Xenocortical mice enter drug development for brain disorders

Likely Resolves by Sep 16, 2027

Discussed by: Reuters and Nature news, citing Pașca's stated goal of testing drugs for autism, schizophrenia, epilepsy, and cerebral palsy

The model's stated purpose is drug testing for neurodevelopmental disorders. Pașca already did this with rats for Timothy syndrome, so extending to xenocortical mice is the natural next step. A peer-reviewed paper reporting a drug candidate tested in xenocortical mice would confirm the pipeline is live.

Human organoid transplants extend to primates or pigs

Unlikely Resolves by Sep 16, 2027

Discussed by: Hongkui Zeng at the Allen Institute, who notes larger animals create bigger ethical issues; Pașca, who calls primate experiments a red line

The team drew a clear red line against primate experiments. Other groups could cross it. Zeng notes pigs and primates live longer, letting human neurons form more meaningful circuits — but the ethical questions grow in kind. If any group publishes such a study, the guardrail is broken.

Formal ethics guidelines codify limits on human-animal brain chimeras

Possible Resolves by Sep 16, 2027

Discussed by: Nita Farahany at Duke Law, who says the work enters "new gray areas for which there are not clear ethical guidelines or norms"

Pașca consulted a Stanford ethics committee and an external board, and Farahany says the team has been thoughtful. If a major research body publishes formal rules — acceptable tissue volumes, growth duration limits, banned host species — the currently informal boundaries would become codified.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

August 2013

First human cerebral organoids (2013)

Madeline Lancaster and Jürgen Knoblich at the Institute of Molecular Biotechnology in Vienna grew "mini-brains" — pea-sized clumps of human neurons — from stem cells. The organoids spontaneously organized into structures resembling early brain regions.

Then

The work opened a new field for studying human neurodevelopment in a dish and prompted immediate speculation about whether the clusters could ever develop consciousness.

Now

Organoid research expanded into disease modeling and drug testing. The consciousness question has followed it ever since.

Why this matters now

The xenocortical mouse work is the next step: organoids moved out of the dish and into a living animal, carrying the same consciousness questions with them.

August 2016

NIH considers funding human-animal chimera research (2016)

The U.S. National Institutes of Health proposed lifting a moratorium on funding research that introduces human stem cells into early animal embryos, a step toward growing human organs in animals. The agency asked for public comment and convened a special advisory committee.

Then

Critics, including some religious groups and bioethicists, objected that such chimeras could blur the line between human and animal. The NIH kept restrictions in place for some experiments.

Now

The debate set a precedent for case-by-case ethics review of chimera research rather than blanket prohibition.

Why this matters now

The same tension — how much human material, in what kind of animal, for what purpose — now applies to brain tissue specifically.

January 2017

Human-pig chimeras created at Salk (2017)

A team led by Juan Carlos Izpisua Belmonte at the Salk Institute injected human stem cells into pig embryos, creating embryos containing a small number of human cells. The embryos were never brought to term; they developed for up to four weeks.

Then

The work demonstrated it was technically possible to chimerize a large animal with human cells and drew heavy ethics scrutiny.

Now

The experiments showed chimeric research is feasible and helped motivate the NIH's policy review of human-animal chimera funding.

Why this matters now

The xenocortical mice are a more direct version of the same ambition — putting human tissue into an animal — but aimed at the brain rather than organs for transplant.